These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 8072220

  • 1. [Prognostic significance of persistent massive proteinuria in progressive IgA nephropathy--a long-term follow-up study].
    Kokubo T, Hiki Y, Tateno S, Kobayashi Y.
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):823-31. PubMed ID: 8072220
    [Abstract] [Full Text] [Related]

  • 2. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Jul; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 3. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J.
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [Abstract] [Full Text] [Related]

  • 4. Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.
    Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S.
    Nephron; 1989 Oct; 53(3):250-6. PubMed ID: 2797345
    [Abstract] [Full Text] [Related]

  • 5. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 6. Remission of proteinuria improves prognosis in IgA nephropathy.
    Reich HN, Troyanov S, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry.
    J Am Soc Nephrol; 2007 Dec; 18(12):3177-83. PubMed ID: 17978307
    [Abstract] [Full Text] [Related]

  • 7. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy.
    Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T.
    Clin Nephrol; 1992 May; 37(5):235-8. PubMed ID: 1606773
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 9. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V, Tesar V, Zabka J, Rychlík I, Merta M, Jirsa M, Stejskalová A, Stejskal J.
    Cas Lek Cesk; 1996 Dec 18; 135(24):803-6. PubMed ID: 9072300
    [Abstract] [Full Text] [Related]

  • 10. [Effect of plasma exchange therapy on IgA nephropathy in children--a retrospective study].
    Tsunoda Y.
    Nihon Jinzo Gakkai Shi; 1995 Apr 18; 37(4):238-46. PubMed ID: 7602811
    [Abstract] [Full Text] [Related]

  • 11. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 18; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 12. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy.
    Abe S.
    Clin Nephrol; 1994 Feb 18; 41(2):61-4. PubMed ID: 8004830
    [Abstract] [Full Text] [Related]

  • 13. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul 18; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 14. Review of cases of IgA nephropathy.
    World MJ.
    J R Army Med Corps; 2013 Jun 18; 159(2):90-3. PubMed ID: 23720589
    [Abstract] [Full Text] [Related]

  • 15. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
    Ren Fail; 2008 Jun 18; 30(6):611-6. PubMed ID: 18661411
    [Abstract] [Full Text] [Related]

  • 16. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep 18; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 17. [Correlation between urinary protein fractions and histological features in IgA nephropathy].
    Matsumura O.
    Nihon Jinzo Gakkai Shi; 1990 Apr 18; 32(4):379-87. PubMed ID: 2376911
    [Abstract] [Full Text] [Related]

  • 18. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
    Am J Kidney Dis; 2006 May 18; 47(5):751-60. PubMed ID: 16632013
    [Abstract] [Full Text] [Related]

  • 19. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK, Yan HD, Hewitson TD, Nicholls KM, Fairley KF, Kincaid-Smith P, Becker GJ.
    Clin Nephrol; 1996 Oct 18; 46(4):225-9. PubMed ID: 8905206
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep 18; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.